SELECT COUNTRY

VIEW ALL

AFRICA

AMERICAS

ASIA

EUROPE

OCEANIA

ALGERIA ANGOLA ARGENTINA AUSTRALIA AZERBAIJAN BAHREIN BELGIUM BENIN BOLIVIA BOTSWANA BRAZIL BRUNEI BURKINA FASO CAMEROON CANADA CENTRAL AFRICAN REPUBLIC CHAD CHILE CHINA COLOMBIA COTE D’IVOIRE CUBA CZECH REPUBLIC DOMINICAN REPUBLIC DRC ECUADOR EGYPT EQUATORIAL GUINEA ETHIOPIA FINLAND FRANCE GABON GHANA GREENLAND GUATEMALA GUINEA GUYANA HUNGARY ICELAND INDIA INDONESIA IRAN IRAQ ITALY JAMAICA JAPAN KAZAKHSTAN KENYA KUWAIT LESOTHO LIBERIA LIBYA MADAGASCAR MALAWI MALAYSIA MALI MAURITANIE MEXICO MONGOLIA MOROCCO MOZAMBIQUE NAMIBIA NETHERLANDS NICARAGUA NIGER NIGERIA NORWAY PANAMA PAPUA NEW GUINEA PARAGUAY PERU PHILIPPINES POLAND QATAR REPUBLIC OF CONGO RUSSIA RWANDA SAUDI ARABIA SENEGAL SIERRA LEONE SINGAPORE SLOVENIA SOMALI SOUTH AFRICA SOUTH KOREA SPAIN SUDAN SWEDEN TAIWAN TANZANIA THAILAND TOGO TRINDAD & TOBAGO TURKEY TURKMENISTAN UAE UGANDA UKRAINE UNITED KINGDOM UNITED STATES VENEZUELA VIETNAM ZAMBIA ZIMBABWE

DOMINICAN REPUBLIC: LATEST INTERVIEWS MORE INTERVIEWS

Marco Garrido Vidaurreta

VP OPERATIONS AND SALES AMERICAS, ENERGOLD DRILLING

"Because our rigs are modular, they can be easily transportable using ATVs, canoes, helicopters, or even by hand, whereas conventional rigs need to be transported via large trucks."

Mining

Peru

Mexico

Brazil

Nicaragua

Dominican Republic

Mark Bristow

PRESIDENT & CEO, BARRICK GOLD

"Our successful exploration programs are feeding high-quality prospects into an already bulging pipeline and we expect to grow our reserves net of depletion again this year."

DOMINICAN REPUBLIC: LATEST ARTICLES

No Content Found

Latam North and Caribbean Mining 2025 - Digital Interactive

June 27, 2025

Central America & Carribean Mining 2013 E&MJ Release

August 07, 2013

RECENT PUBLICATIONS

United States Life Sciences 2025 - Digital Interactive

Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.

MORE PREVIOUSLY PUBLISHED

PARTNER EVENTS

SEE ALL